D-galactosamine and acute liver cell injury.
D000818:Animals; D002466:Cell Nucleolus; D002467:Cell Nucleus; D002498:Centrifugation; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004721:Endoplasmic Reticulum; D005260:Female; D005688:Galactosamine; D006023:Glycoproteins / Q000096:biosynthesis; D006168:Guinea Pigs; D006595:Hexosamines / Q000378:metabolism; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008854:Microscopy, Electron; D009336:Necrosis; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D011817:Rabbits; D051381:Rats; D012270:Ribosomes; D014500:Uracil Nucleotides / Q000378:metabolism; D014529:Uridine / Q000494:pharmacology; D014539:Uridine Diphosphate Sugars / Q000378:metabolism
D006023:Glycoproteins; D006595:Hexosamines; D014500:Uracil Nucleotides; D014539:Uridine Diphosphate Sugars; D012313:RNA; D005688:Galactosamine; D012321:DNA-Directed RNA Polymerases; D014529:Uridine